These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33447693)

  • 1. Impacts of Inflammation-Based Prognostic Scores on Survival in Patients With Hypopharyngeal Squamous Cell Carcinoma.
    Iuchi H; Kyutoku T; Ito K; Matsumoto H; Ohori J; Yamashita M
    OTO Open; 2020; 4(4):2473974X20978137. PubMed ID: 33447693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of the Modified and High-Sensitivity Modified Glasgow Prognostic Scores for Hypopharyngeal Squamous Cell Carcinoma.
    Iuchi H; Ohori J; Matsuzaki H; Kiyama S; Yamashita M
    OTO Open; 2021; 5(4):2473974X211067423. PubMed ID: 34950840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presurgical platelet-lymphocyte ratio for prognosis in advanced hypopharyngeal squamous cell carcinoma in individuals undergoing radical resection.
    Chen H; Song S; Li A; Ma D; Lin C; Qian X; Gao X; Shen X
    Acta Otolaryngol; 2021 May; 141(5):537-543. PubMed ID: 33872102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Role of High-Sensitivity Modified Glasgow Prognostic Score for Patients With Operated Oral Cavity Cancer: A Retrospective Study.
    Tsai YT; Fang KH; Hsu CM; Lai CH; Chang SW; Huang EI; Tsai MS; Chang GH; Luan CW
    Front Oncol; 2022; 12():825967. PubMed ID: 35242712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101.
    He CB; Lin XJ
    PLoS One; 2017; 12(3):e0174769. PubMed ID: 28355305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte to Monocyte Ratio and Modified Glasgow Prognostic Score Predict Prognosis of Lung Adenocarcinoma Without Driver Mutation.
    Minami S; Ihara S; Kim SH; Yamamoto S; Komuta K
    World J Oncol; 2018 Feb; 9(1):13-20. PubMed ID: 29581811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic values of systemic inflammation and nutrition-based prognostic indices in oropharyngeal carcinoma.
    Oka T; Sato F; Ono T; Kawaguchi T; Murotani K; Sueyoshi S; Kuroiwa T; Kurita T; Fukahori M; Mitsuhashi T; Sato K; Chitose SI; Umeno H
    Laryngoscope Investig Otolaryngol; 2023 Jun; 8(3):675-685. PubMed ID: 37342125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic inflammatory response in predicting outcomes of patients undergoing curative resection for oral squamous cell carcinoma.
    Zubair F; McMahon J; Kryklyas G; Wicks C
    Br J Oral Maxillofac Surg; 2022 Jun; 60(5):589-595. PubMed ID: 35248409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of inflammation-based markers for predicting the prognosis of unresectable pancreatic ductal adenocarcinoma treated with chemotherapy.
    Asama H; Suzuki R; Takagi T; Sugimoto M; Konno N; Watanabe K; Nakamura J; Kikuchi H; Takasumi M; Sato Y; Irie H; Hikichi T; Ohira H
    Mol Clin Oncol; 2018 Oct; 9(4):408-414. PubMed ID: 30233794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio.
    Wei XL; Wang FH; Zhang DS; Qiu MZ; Ren C; Jin Y; Zhou YX; Wang DS; He MM; Bai L; Wang F; Luo HY; Li YH; Xu RH
    BMC Cancer; 2015 May; 15():350. PubMed ID: 25934640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of systemic inflammation-based markers in advanced pancreatic cancer.
    Martin HL; Ohara K; Kiberu A; Van Hagen T; Davidson A; Khattak MA
    Intern Med J; 2014 Jul; 44(7):676-82. PubMed ID: 24750233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Combined Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Stage IV Advanced Gastric Cancer.
    Wang H; Ding Y; Li N; Wu L; Gao Y; Xiao C; Jiang H; Zheng Y; Mao C; Deng J; Wang H; Xu N
    Front Oncol; 2020; 10():841. PubMed ID: 32637353
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic Value of Inflammation Biomarkers for Survival of Patients with Neuroblastoma.
    Zheng C; Liu S; Feng J; Zhao X
    Cancer Manag Res; 2020; 12():2415-2425. PubMed ID: 32280277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Inflammation-Based Prognostic Score, the C-Reactive Protein/Albumin Ratio Predicts the Prognosis of Patients with Operable Esophageal Squamous Cell Carcinoma.
    Xu XL; Yu HQ; Hu W; Song Q; Mao WM
    PLoS One; 2015; 10(9):e0138657. PubMed ID: 26390126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment Lymphocyte to Monocyte Ratio as a Prognostic Marker for Advanced Pulmonary Squamous Cell Carcinoma Treated With Chemotherapy.
    Minami S; Ihara S; Komuta K
    J Clin Med Res; 2018 Aug; 10(8):657-664. PubMed ID: 29977424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer.
    Sun X; Liu X; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z
    Chin J Cancer; 2016 Jun; 35(1):57. PubMed ID: 27342313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glasgow prognostic score and neutrophil-lymphocyte ratio are good prognostic indicators after radical neck dissection for advanced squamous cell carcinoma in the hypopharynx.
    Ikeguchi M
    Langenbecks Arch Surg; 2016 Sep; 401(6):861-6. PubMed ID: 27236289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation-based prognostic scores predict the prognosis of locally advanced cervical esophageal squamous cell carcinoma patients receiving curative concurrent chemoradiotherapy: a propensity score-matched analysis.
    Wu CC; Li SH; Lu HI; Lo CM; Wang YM; Chou SY; Chen YH
    PeerJ; 2018; 6():e5655. PubMed ID: 30258731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appraisal of inflammation-based prognostic scores in patients with unresectable perihilar cholangiocarcinoma.
    Okuno M; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
    J Hepatobiliary Pancreat Sci; 2016 Oct; 23(10):636-642. PubMed ID: 27474781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sixth-Week Immune-Nutritional-Inflammatory Biomarkers: Can They Predict Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors?
    Olgun P; Diker O
    Curr Oncol; 2023 Dec; 30(12):10539-10549. PubMed ID: 38132403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.